Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

Trials and Tribulations of MicroRNA Therapeutics

In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122